Comparison of the kappa-opioid receptor antagonist DIPPA in tests of anxiety-like behavior between Wistar Kyoto and Sprague Dawley rats
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
RationaleRecent evidence suggests a role for the dynorphin/kappa-opioid receptor (KOR) system in the expression of stress-induced behaviors. Wistar Kyoto (WKY) rats exhibit increased depression-like and anxiety-like responses in behavioral tests compared to other strains and may be a model of comorbid depression and anxiety characterized by increased activity within the dynorphin/KOR system. Though KOR antagonists produce antidepressant-like effects in WKY rats, their effects in tests of anxiety-like behavior have not been examined in the WKY strain.ObjectiveThe aim of the current study was to investigate the effects of the KOR antagonist 2-(3,4-dichlorophenyl)-N-methyl-N-[(1S)-1-(3-isothiocyanatophenyl)-2-(1-pyrrolidinyl)ethyl]acetamide hydrochloride (DIPPA) on the behavior of WKY rats and Sprague Dawley (SD) rats in tests of anxiety-like behavior.MethodsThe novelty-induced hypophagia and defensive burying tests were used to measure anxiety-like behavior in WKY and SD rats and determine the effects of DIPPA on anxiety-like behavior in both strains.ResultsWKY rats displayed greater amounts of anxiety-like behavior compared to SD rats. DIPPA produced anxiolytic-like effects in both tests in both strains.ConclusionsWKY rats display more anxiety-like behavior at baseline compared to SD rats, and DIPPA produced anxiolytic-like effects in both WKY and SD rats. These findings support previous research suggesting that KOR antagonists possess anxiolytic-like properties and may potentially represent a novel class of treatments for mood disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genetic Epidemiology of Major Depression: Review and Meta-Analysis
Sullivan, P. F., Neale, M. C., & Kendler, K. S. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.10.1552 · Cited by 3,431 · cited 2×
“Given the interplay between environmental stressors and genetic vulnerability in the development of mood disorders (Sullivan et al. 2000), animal models that exhibit increased trait anxiety and stress sensitivity could help identify potential therapeutic agents for the treatment of comorbid depression and anxiety.”
Fava, M., Rush, A. J., Alpert, J. E., Balasubramani, G. K., Wisniewski, S. R., Carmin, C. N., Biggs, M. M., Zisook, S., Leuchter, A., Howland, R., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06111868 · Cited by 927
Sareen, J., Cox, B. J., Afifi, T. O., de Graaf, R., Asmundson, G. J. G., ten Have, M., & Stein, M. B. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.11.1249 · Cited by 824
Effects of Chronic Fluoxetine in Animal Models of Anxiety and Depression
Dulawa, S. C., Holick, K. A., Gundersen, B., & Hen, R. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300433 · Cited by 671 · cited 3×
“Anxiolytic compounds reduce the latency to approach food and increase feeding in the NIH test (Bechtholt et al. 2008; Dulawa et al. 2004; Merali et al. 2003).”
The Dysphoric Component of Stress Is Encoded by Activation of the Dynorphin κ-Opioid System
Land, B. B., Bruchas, M. R., Lemos, J. C., Xu, M., Melief, E. J., & Chavkin, C. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4458-07.2008 · Cited by 601
The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors
Bruchas, M. R., Land, B. B., & Chavkin, C. (2010) · Brain Research · doi:10.1016/j.brainres.2009.08.062 · Cited by 544 · cited 1×
“A large body of evidence suggests that the dynorphin/ kappa-opioid receptor (KOR) system is an important biological substrate underlying aversion related to depression and anxiety (Bruchas et al. 2009; Knoll and Carlezon 2009).”
Dynorphin, stress, and depression
Knoll, A. T., & Carlezon, W. A. (2010) · Brain Research · doi:10.1016/j.brainres.2009.09.074 · Cited by 465
The effects of chronic antidepressant treatment in an animal model of anxiety
Bodnoff, S., Suranyi-Cadotte, B., Aitken, D., Quirion, R., & Meaney, M. (1988) · Psychopharmacology · doi:10.1007/bf00181937 · Cited by 437 · cited 5×
“But other studies have focused exclusively on approach latencies (Bodnoff et al. 1988) or food consumption (Britton and Britton 1981) measures alone.”
InfluentialConditioned defensive burying: A new paradigm for the study of anxiolytic agents
Treit, D., Pinel, J. P. J., & Fibiger, H. C. (1981) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(81)90219-7 · Cited by 420 · cited 3×
“The DB test typically measures the effects of anxiolytic drugs with a reduction in burying behavior (Treit et al. 1981).”
Do animal models of anxiety predict anxiolytic-like effects of antidepressants?
Borsini, F., Podhorna, J., & Marazziti, D. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1155-6 · Cited by 347 · cited 1×
“Novelty suppression of feeding tests are some of the few tests of anxiety-like behavior that are responsive to the anxiolytic effects of antidepressants (Bechtholt et al. 2008; Bodnoff et al. 1988; Borsini et al. 2002; Dulawa et al. 2004).”
Social Defeat Stress-Induced Behavioral Responses are Mediated by the Endogenous Kappa Opioid System
McLaughlin, J. P., Li, S., Valdez, J., Chavkin, T. A., & Chavkin, C. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300872 · Cited by 253
Grillon, C., Levenson, J., & Pine, D. S. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301204 · Cited by 162 · cited 1×
“In fact, treatment with antidepressants can often induce or exacerbate anxiety before therapeutic effects have had an opportunity to emerge (Grillon et al. 2007; Marshall et al. 1995; Zinner 1994).”
Validation of a simple, ethologically relevant paradigm for assessing anxiety in mice
Merali, Z., Levac, C., & Anisman, H. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01827-9 · Cited by 157 · cited 1×
“Anxiolytic compounds reduce the latency to approach food and increase feeding in the NIH test (Bechtholt et al. 2008; Dulawa et al. 2004; Merali et al. 2003).”
Comorbid anxiety as a suicide risk factor among depressed veterans
Pfeiffer, P. N., Ganoczy, D., Ilgen, M., Zivin, K., & Valenstein, M. (2009) · Depression and Anxiety · doi:10.1002/da.20583 · Cited by 153
A comparison of anxiolytic and nonanxiolytic agents in the shock-probe/burying test for anxiolytics
Treit, D. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90151-7 · Cited by 86 · cited 1×
“Anxiolytic compounds decrease burying behavior in the DB test (Treit 1990; Treit et al. 1981), and anxiogenic drugs increase the duration of burying (De Boer and Koolhaas 2003).”
Bechtholt, A. J., Valentino, R. J., & Lucki, I. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301616 · Cited by 40 · cited 7×
“This training allowed the development of stable latency and consumption levels (Bechtholt et al., 2008).”
InfluentialSelf-citation
Cited by
Role of kappa-opioid receptors in stress and anxiety-related behavior
Van’t Veer, A., & Carlezon, W. A. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3195-5 · Cited by 257
Bali, A., Randhawa, P. K., & Jaggi, A. S. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.12.018 · Cited by 133
Pérez de la Mora, M., Borroto-Escuela, D. O., Crespo-Ramírez, M., Rejón-Orantes, J. D. C., Palacios-Lagunas, D. A., Martínez-Mata, M. K., Sánchez-Luna, D., Tesoro-Cruz, E., & Fuxe, K. (2022) · Cells · doi:10.3390/cells11111826 · Cited by 21
The Antidepressant Effect of Magnolol on Depression-Like Behavior of CORT-Treated Mice
Xu, C., Ye, J., Sun, Y., Sun, X., & Liu, J.-G. (2024) · Journal of Molecular Neuroscience · doi:10.1007/s12031-023-02185-0 · Cited by 8
Metadata
- Authors
- Carr, G. V., & Lucki, I.
- Venue
- Psychopharmacology
- Published
- 2010-04-06
- Volume
- 210
- Issue
- 2
- Pages
- 295-302
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W1994472137
- Cited by
- 70
- References
- 16
- FWCI
- 2.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.